𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No-carrier-added meta-[123I]iodobenzylguanidine: Synthesis and preliminary evaluation

✍ Scribed by Ganesan Vaidyanathan; Michael R. Zalutsky

Book ID
116171974
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
403 KB
Volume
22
Category
Article
ISSN
0969-8051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No-carrier-added synthesis of meta-[131I
No-carrier-added synthesis of meta-[131I]iodobenzylguanidine
✍ Ganesan Vaidyanathan; Michael R. Zalutsky 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 806 KB

No-carrier-added meta-[131I]iodobenzylguanidine ([131I]MIBG) was prepared starting with two different metallated precursors. Attempted preparation of 3-(tri-n-butylstannyl)benzylguanidine was not successful. An alternate two-step strategy using 3-(tri-n-butylstannyl)benzylamine could be used to prep

A rapid high yield synthesis of no-carri
A rapid high yield synthesis of no-carrier-added (-)-[123I]iodocyanopindolol
✍ Marcian E. Van Dort; David L. Gildersleeve; Donald M. Wieland 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 331 KB

A convenient and efficient radiosynthesis of no-carrier-added [123I]labeled (-)iodocyanopindolol, (-)-[123I]ICYP, a high affinity beta adrenergic antagonist, is described. (-)-[123I]ICYP was synthesized by a modified chloramine-T radioiodination of (-)cyanopindolol followed by a novel reversed-phase

Synthesis and binding to striatal membra
Synthesis and binding to striatal membranes of no carrier added I-123 labeled 4′-iodococaine.
✍ S. A. M. Metwally; S. J. Gatley; A. P. Wolf; D.-W. Yu 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 320 KB

## Abstract An ^123^I labeled cocaine analog, 4′‐[^123^I]iodococaine, has been prepared by oxidative destannylation of the tributyltin analog and shown to interact with cocaine binding sites in rat brain striatal membranes. It may thus be a suitable SPECT radiotracer for studies of the dopamine reu

Large-scale synthesis of no-carrier-adde
Large-scale synthesis of no-carrier-added [123I]mIBG, using two different stannylated precursors
✍ Daniel D. Rossouw; Lebohang Macheli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB

## Abstract The clinical advantages of no‐carrier‐added (n.c.a) radioiodinated meta‐iodobenzylguanidine ([\*I]mIBG) over its carrier‐added (c.a.) analogue have previously been reported. A large‐scale synthesis of n.c.a. [^123^I]mIBG was therefore investigated in this study, using a slightly adapted